{"id":"NCT01353079","sponsor":"Greer Laboratories","briefTitle":"Efficacy and Safety Study Of Short Ragweed Pollen Sublingual-Oral Immunotherapy","officialTitle":"Randomized, Double-Blind, Placebo-Controlled, Parallel Group Efficacy And Safety Trial Of Sublingual-Oral Immunotherapy (SLIT) In Adults With Allergic Rhinoconjunctivitis Caused By Ragweed Pollen","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-04","primaryCompletion":"2011-11","completion":"2012-04","firstPosted":"2011-05-12","resultsPosted":"2015-02-05","lastUpdate":"2015-02-05"},"enrollment":429,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Allergy"],"interventions":[{"type":"BIOLOGICAL","name":"Short Ragweed Pollen Allergenic Extract","otherNames":[]},{"type":"BIOLOGICAL","name":"Placebo","otherNames":[]}],"arms":[{"label":"Short Ragweed Pollen Allergenic Extract","type":"EXPERIMENTAL"},{"label":"Glycero-COCAs","type":"PLACEBO_COMPARATOR"}],"summary":"The primary objective of this study is to demonstrate that SLIT administered pre-and co-seasonally is effective in reducing rhinoconjunctivitis symptoms during the entire short ragweed pollen season.","primaryOutcome":{"measure":"Scores on a Scale [Net Average Combined Daily Rhinoconjunctivitis Symptom (RSS) and Medication Scores]","timeFrame":"2011 ragweed pollen season, 8/2011 -10/2011","effectByArm":[{"arm":"Ragweed Allergenic Extract","deltaMin":0.853,"sd":1.64},{"arm":"Placebo (Glycero-Cocas)","deltaMin":1.687,"sd":2.4}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.05"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":10},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":218},"commonTop":["Headache","Upper Respiratory Tract Infection"]}}